![]() |
|
|
Vol. 285, Issue 1, 41-53, April 1998
Behavioral Biology Research Center, Department of
Psychiatry and Behavioral Sciences, Johns Hopkins University School of
Medicine, Baltimore, Maryland
The current study examined behavioral effects and possible development
of physical dependence after once-daily doses of zolpidem (0, 1.0, 3.2, 10.0, 32.0 mg/kg intragastrically [i.g.]) in three baboons. Each dose
was administered for 17 days and then the dose was increased; the 32.0 mg/kg dose was administered for 27 days. Baboons had access to food
pellets for 20 hr/day beginning 15 min after dosing. Each day, baboons
were presented with a fine motor task. Observation sessions were
conducted 1 hr after dosing on days 1, 10, 12 and 14 of each dose
condition and after termination of drug dosing. On days 10 and 14 of
each dose condition, vehicle and flumazenil (5 mg/kg i.m.) were
administered, respectively. Zolpidem increased the number of pellets
obtained by two of three baboons. Vomit and/or retch and grimace (signs
believed to be indicative of abdominal discomfort) were observed in one
or two baboons during all zolpidem dose conditions (1.0-32.0 mg/kg). Time to complete the fine motor task increased dose-dependently in all
three baboons, and incoordination was observed during the task in two
baboons at 10.0 and 32.0 mg/kg. Analysis of blood plasma showed that
measurable levels of zolpidem were present 24 hr after dosing in all
drug conditions. The signs of flumazenil-precipitated withdrawal were
summarized on a 9-point scale. Scores ranged from 1 to 5 in the 1.0 mg/kg condition, from 2 to 5 in the 3.2 and 10.0 mg/kg conditions and
from 4 to 6 in the 32.0 mg/kg condition. Signs that were considered
intermediate in severity were observed. Specifically, tremor, jerk
and/or rigidly braced posture was observed in one baboon at 1.0 mg/kg,
two baboons at the next two doses and all three baboons at 32.0 mg/kg.
Vomit and/or retch also occurred in two baboons at dose conditions
above 1.0 mg/kg. Discontinuation of zolpidem dosing after 78 to 79 days
resulted in mild withdrawal signs (e.g., number of
pellets obtained were lower and number of 1-min intervals increased in
which eyes were closed, or in which lying down, head lower than torso
posture and/or withdrawn posture were observed) on the first day in two
baboons. The peak withdrawal scores were 4 or 5 on days 5 to 10; two
baboons vomited and/or retched and all three baboons showed tremor,
jerk and/or rigidly braced posture. Thus, zolpidem produced physical
dependence under once-daily dosing conditions, and the severity of the
withdrawal syndrome can be characterized as intermediate.
This article has been cited by other articles:
![]() |
T. Capua and C. M. Shapiro Commentary on a critique for the Journal of Psychopharmacology: NICE -excellence or eccentricity? Reflections on the z-drugs as hypnotics review J Psychopharmacol, January 1, 2007; 21(1): 114 - 117. [PDF] |
||||
![]() |
N. R. Mirza and E. O. Nielsen Do Subtype-Selective {gamma}-Aminobutyric AcidA Receptor Modulators Have a Reduced Propensity to Induce Physical Dependence in Mice? J. Pharmacol. Exp. Ther., March 1, 2006; 316(3): 1378 - 1385. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R Rappa, M. Larose-Pierre, D. R Payne, N. E Eraikhuemen, D. M Lanes, and M. L Kearson Detoxification from High-Dose Zolpidem Using Diazepam Ann. Pharmacother., April 1, 2004; 38(4): 590 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. A. Liappas, P. N. Malitas, N. P. Dimopoulos, O. E. Gitsa, A. I. Liappas, Ch. K. Nikolaou, and G. N. Christodoulou Zolpidem dependence case series: possible neurobiological mechanisms and clinical management J Psychopharmacol, January 1, 2003; 17(1): 131 - 135. [Abstract] [PDF] |
||||
![]() |
S. Lelas, L. R. Gerak, and C. P. France Antagonism of the Discriminative Stimulus Effects of Positive gamma -Aminobutyric AcidA Modulators in Rhesus Monkeys Discriminating Midazolam J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 902 - 908. [Abstract] [Full Text] |
||||